Citadel Advisors’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2015
Q1 | – | Hold |
0
| – | – | – | 4357 |
|
2014
Q4 | – | Sell |
-1,691,547
| Closed | -$20.2M | – | 4191 |
|
2014
Q3 | $20.2M | Buy |
1,691,547
+491,925
| +41% | +$5.86M | 0.02% | 596 |
|
2014
Q2 | $6.77M | Buy |
1,199,622
+1,187,128
| +9,502% | +$6.7M | 0.01% | 970 |
|
2014
Q1 | $46K | Sell |
12,494
-102,582
| -89% | -$378K | ﹤0.01% | 3307 |
|
2013
Q4 | $386K | Sell |
115,076
-26,739
| -19% | -$89.7K | ﹤0.01% | 2166 |
|
2013
Q3 | $602K | Buy |
141,815
+55,835
| +65% | +$237K | ﹤0.01% | 1794 |
|
2013
Q2 | $396K | Buy |
+85,980
| New | +$396K | ﹤0.01% | 2020 |
|